Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PDRN and Fractional CO2 Laser for Facial Scar Remodeling
NCT07472192Phase 2Recruiting
- Sponsor
- Misr University for Science and Technology
- Start
- Mar 2026
- Primary completion
- Jul 2026
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of polideoxirybonucleotide in facial scarring, sponsored by Misr University for Science and Technology. Started Mar 2026; status: recruiting.
02
Drugs
polideoxirybonucleotide
03
Conditions
facial scarring
Beyond the preview
Go deeper on NCT07472192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07472192.